Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQ0I4N
|
|||
| Drug Name |
RP-L201
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Leukocyte adhesion deficiency type 1 [ICD-11: 4A00.0Y ] | Phase 1/2 | [1] | |
| Company |
Rocket Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03812263) A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Rocket Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.